McKesson Corp. (MCK)

148.92
NYSE : Distribution Services
Prev Close 150.99
Day Low/High 148.85 / 151.53
52 Wk Low/High 134.25 / 178.86
Avg Volume 1.61M
Exchange NYSE
Shares Outstanding 206.34M
Market Cap 30.87B
EPS 23.40
P/E Ratio 6.89
Div & Yield 1.36 (0.87%)

Latest News

What to Expect From Trump's Speech on Drug Prices on Friday

What to Expect From Trump's Speech on Drug Prices on Friday

Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.

Analyst Favorites With Strong Buyback Activity: McKesson Ranks As A Top Pick

A study of analyst recommendations at the major brokerages shows that McKesson Corp is the #44 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

Congressional Committee Grills Drug Distributors on Opioid Crisis Roles

Congressional Committee Grills Drug Distributors on Opioid Crisis Roles

One drug distribution executive appearing before a House Committee to answer for shipping millions of doses of opioids into West Virginia apologized and another said his company had a hand in the crisis.

Cardinal Health Plunges After Negative Earnings Revision

Cardinal Health Plunges After Negative Earnings Revision

Cardinal Health had its worst day of trading in 14 years.

Global Stocks Gain as 'Merger Monday' Descends on Wall Street

Global Stocks Gain as 'Merger Monday' Descends on Wall Street

Global stocks kicked-off the week in a bullish mood Monday, with merger activity and a robust U.S. corporate earnings season helping boost markets in Europe and Asia and set up Wall Street for a positive start to the final trading day of the month.

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

An internal review of management behavior at the healthcare company over opioid distribution prompted by complaints from shareholder International Brotherhood of Teamsters gives company officials a clean bill of health.

Sohn Investing 2018: An Insider's Recap

Sohn Investing 2018: An Insider's Recap

Doubleline's Gundlach Launches Facebook Short Campaign, Greenlight's Einhorn believes Assured Guarantee has massive losses "baked in" while Bill Ackman Protégé Scott Ferguson eyes a break up of Britain's WhitBread plc.

Jim Cramer: It's All About Expectations

Jim Cramer: It's All About Expectations

Earnings season is already seeing some wacky effects.

Congress Sets Opioid Hearing Next Month for Drug Distributors

Congress Sets Opioid Hearing Next Month for Drug Distributors

A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.

McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight

McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight

McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.

Searching For Buy Signals; Activists Pile Into United Technologies - ICYMI

Searching For Buy Signals; Activists Pile Into United Technologies - ICYMI

Amid the decline there were some winners including Red Hat and McCormick. Twitter gets a new short-seller and more activist action at United Technologies, dot a busy Tuesday. Here's what you may have missed.

Trump Opioid Policy Rollout Includes Call for Death Penalty for Dealers

Trump Opioid Policy Rollout Includes Call for Death Penalty for Dealers

President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.

Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids

Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids

A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.

Attorney General Sessions Announces New Federal Opioids Taskforce

Attorney General Sessions Announces New Federal Opioids Taskforce

After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.

McKesson Corporation Announces Pricing Of Tender Offer

McKesson Corporation Announces Pricing Of Tender Offer

McKesson Corporation (NYSE: MCK) (the "Company") today announced the determination of the Full Tender Offer Consideration, as shown in the table below, for its previously announced cash tender offer to purchase up to...

See How McKesson Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How McKesson Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that McKesson Corp is the #33 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.

McKesson Corporation Announces Early Tender Results

McKesson Corporation Announces Early Tender Results

McKesson Corporation (NYSE: MCK) (the "Company") today announced the early tender results as of the Early Tender Time (as defined below) in connection with its previously announced cash tender offer to purchase up to...

House Committee: 2 Pharmacy Managers Sent 12.3 Million Opioid Doses to 1 Store

House Committee: 2 Pharmacy Managers Sent 12.3 Million Opioid Doses to 1 Store

McKesson and Cardinal Health are alleged to have sent more than 12 million opioid doses to a single pharmacy in West Virginia over an eight-year period, according to a House committee probe.

Who Says There Are No Second Chances?

Who Says There Are No Second Chances?

A follow-up on my stock pick of the year, McKesson.

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

In the last two weeks alone, three sectors have gotten hammered on announcements or reports about Amazon's plans.

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing

The White House Council of Economic Advisers on Friday, Feb. 9, released a report on how the government can help bring down drug prices.

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.

McKesson Reports Fiscal 2018 Third-Quarter Results

McKesson Reports Fiscal 2018 Third-Quarter Results

McKesson Corporation (NYSE:MCK) today reported that revenues for the third quarter ended December 31, 2017, were $53.

TheStreet Quant Rating: C+ (Hold)